Shares of Carl Icahn’s conglomerate Icahn Enterprises experienced a sharp sell-off Friday after the firm slashed its quarterly dividend in half amid notable short seller Hindenburg Research’s campaign.
IEP announced it issued a $1 per depositary unit distribution, which represents a 12% annualized yield. That’s compared with a $2 dividend in the previous quarter. The stock tanked a whopping 23.2% after the news.
Icahn’s company has been on a roller-coaster ride since the Nathan Anderson-led short seller took a public short position in May, alleging “inflated” asset valuations, among other reasons. Shares of IEP, a holding company that is involved in myriad businesses including energy, automotive and real estate, tumbled nearly 44% in the second quarter. The stock is down 50.5% year to date.
Hindenburg took issue with IEP’s high dividend yield, saying it’s “unsupported” by the company’s cash flow and investment performance.
“The payment of future distributions will be determined by the board of directors quarterly, based upon current economic conditions and business performance and other factors,” 87-year-old investor Icahn said in a statement Friday. “We do not intend to let a misleading Hindenburg report interfere with this practice.”
Icahn Enterprises on Friday reported a net loss of $269 million for the second quarter, more than doubling the loss of $128 million from the same quarter a year ago. Icahn attributed the disappointing quarter to the short selling activity in his controlling companies and investments.
“I believe the second quarter partially reflected the impact of short-selling on companies we control or invest in, which I attribute to the misleading and self-serving Hindenburg report concerning our company. It also reflected the size of the hedge book relative to our activist strategy,” Icahn said.
Icahn, the most well-known corporate raider in history, made his name after pulling off a hostile takeover of Trans World Airlines in the 1980s, stripping the company of its assets. Most recently, the billionaire investor has engaged in activist investing in McDonald’s and biotech firm Illumina
